What is the difference between cosmetic claims and drug claims for baby care in the U.S.?

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

• Cosmetic claims for baby care, such as ‘gentle cleansing’ or ‘softens skin,’ fall under FDA cosmetic regulation, which does not require pre-market approval.
• Drug claims, like ‘prevents or treats diaper rash’ or ‘antibacterial,’ classify the product as an over-the-counter (OTC) drug, subject to FDA drug rules under the FD&C Act.
• This distinction is critical for compliance, as drug products must meet specific monograph requirements or undergo New Drug Application (NDA) processes.
• For OEM/ODM projects, we guide clients through claim vetting to avoid misbranding and ensure market entry.
• In production, formulating for drug claims often involves active ingredients like zinc oxide, which may affect MOQs due to specialized sourcing and stability testing.
• Sampling for drug claims typically takes 4-6 weeks longer than cosmetics, as we conduct efficacy and safety tests per FDA guidelines.
• Packaging must include Drug Facts labeling and may require child-resistant features, impacting lead times by 2-3 weeks.
• We support documentation like ingredient lists, test reports (e.g., microbiological, stability), and FDA registration assistance, but cannot guarantee regulatory approval.
• Lead time for drug-claim products averages 12-16 weeks from sampling to production, versus 8-10 weeks for cosmetics, due to additional QA checks for potency and purity.